| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/24/2004 | US6779382 Process for determining changes in liquid media, in particular coating agents under shear stress |
| 08/24/2004 | US6779377 Method and apparatus for the calibration of fiber stock consistency sensors |
| 08/24/2004 | CA2458827A1 Detection of agglutination of assays |
| 08/24/2004 | CA2458824A1 Genetic engineering of streptavidin-binding peptide tagged single-chain variable fragment antibody to venezuelan equine encephalitis virus |
| 08/24/2004 | CA2434425A1 Molecularly-imprinted chemical detection device and method |
| 08/24/2004 | CA2320750C System and method of aspirating and dispensing reagent |
| 08/24/2004 | CA2285794C Improved assay for the detection of creatinine |
| 08/24/2004 | CA2223607C Breath testing apparatus |
| 08/24/2004 | CA2158719C Sensor arrangement for temperature measurement |
| 08/24/2004 | CA2096347C A method for stably storing a pharmaceutical |
| 08/24/2004 | CA2081782C Permanent human hepatocyte cell line and its use in a liver assist device (lad) |
| 08/19/2004 | WO2004070643A2 Method for predicting protein function |
| 08/19/2004 | WO2004070389A1 Assay for protein isoforms |
| 08/19/2004 | WO2004070388A1 Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases |
| 08/19/2004 | WO2004070387A1 Improved method of detection of hcv antibodies in combination assay or sole antibody assay |
| 08/19/2004 | WO2004070386A2 Novel screening method |
| 08/19/2004 | WO2004070385A1 A method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual |
| 08/19/2004 | WO2004070384A1 Performance improvement for hematology analysis |
| 08/19/2004 | WO2004070383A2 Identification of pain-regulated gene in the dorsal root ganglion (drg) after cfa-induced arthritis |
| 08/19/2004 | WO2004070382A2 Biosensor, method for the production thereof, and measuring apparatus and method for biological samples |
| 08/19/2004 | WO2004070380A1 Method for the detection of carbon monoxide in a hydrogen-rich gas stream |
| 08/19/2004 | WO2004070379A1 Method of lipoprotein analysis and analytical program |
| 08/19/2004 | WO2004070373A1 Method for manufacturing electrochemical sensor and structure thereof |
| 08/19/2004 | WO2004070372A1 Target recognition element and biosensor including the same |
| 08/19/2004 | WO2004070368A1 Apparatus and method for blood analysis |
| 08/19/2004 | WO2004070355A2 Wafer inspection using a nonvibrating contact potential difference probe (nonvibrating kelvin probe) |
| 08/19/2004 | WO2004070353A2 Method and apparatus for processing assay test results |
| 08/19/2004 | WO2004070352A2 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 08/19/2004 | WO2004070351A2 Protein fragment complementation assays for high-throughput and high-content screening |
| 08/19/2004 | WO2004070347A2 Screening for modulators of fat storage |
| 08/19/2004 | WO2004070345A2 Age determination on death |
| 08/19/2004 | WO2004070344A2 Method of screening for agents which modulate the activity of tlr9 |
| 08/19/2004 | WO2004070320A1 Device and method for determining and/or monitoring a process variable of a medium |
| 08/19/2004 | WO2004070062A2 Compositions and methods for diagnosing and treating cancers |
| 08/19/2004 | WO2004070061A1 Methods for nucleic acid analysis |
| 08/19/2004 | WO2004070057A2 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome |
| 08/19/2004 | WO2004070051A2 Chemical proteomics |
| 08/19/2004 | WO2004070013A2 Use of islet 1 as a marker for isolating or generating stem cells |
| 08/19/2004 | WO2004070012A2 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | WO2004070006A2 Nucleic acid antigens embedded in thermoplastic |
| 08/19/2004 | WO2004070004A2 Rat receptor tyrosine kinase, kdr |
| 08/19/2004 | WO2004070003A2 Methods for selecting and screening for trasformants |
| 08/19/2004 | WO2004069999A2 Screening method |
| 08/19/2004 | WO2004069988A1 High-density cell array board, process for producing the same and method of using the same |
| 08/19/2004 | WO2004069987A1 Culture apparatus |
| 08/19/2004 | WO2004069983A2 Microreactor architecture and methods |
| 08/19/2004 | WO2004069876A2 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | WO2004069863A2 Constrained hiv v3 loop peptides as immunogens and receptor antagonists |
| 08/19/2004 | WO2004069860A2 Isg15-conjugated proteins |
| 08/19/2004 | WO2004069795A2 Diagnosis and treatment of chronic tissue damage |
| 08/19/2004 | WO2004069751A2 Apparatus and method of portable automated biomonitoring of water quality |
| 08/19/2004 | WO2004069737A2 Articles with dispersed conductive coatings |
| 08/19/2004 | WO2004069736A2 Articles with protruding conductive coatings |
| 08/19/2004 | WO2004069268A1 REGENERATION AND NEOGENESIS OF RETINAL VISUAL CELL WITH Otx2 GENE |
| 08/19/2004 | WO2004069258A2 Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 08/19/2004 | WO2004069233A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | WO2004069194A2 Use of the oxidoreductase ncb50r for diagnosings and treating diabetes |
| 08/19/2004 | WO2004069193A2 Methods and compositions for inhibiting cholesterol uptake |
| 08/19/2004 | WO2004069191A2 Identification of t1r and t2r modulators |
| 08/19/2004 | WO2004069189A2 Methods of assessment of drug metabolizing enzymes |
| 08/19/2004 | WO2004069184A2 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | WO2004069175A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON’S DISEASE AND OTHER α-SYNUCLEINOPATHIES |
| 08/19/2004 | WO2004069174A2 Monitoring and treatment of amyotrophic lateral sclerosis |
| 08/19/2004 | WO2004069166A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | WO2004069142A2 Anti-candida agents for the treatment of prion diseases |
| 08/19/2004 | WO2004069131A1 Method and device for testing the breakability and the breaking accuracy of tablets |
| 08/19/2004 | WO2004068931A2 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | WO2004061408A3 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |
| 08/19/2004 | WO2004060390A3 Use of a specific inhibitor of the 5ht2b receptor for the treatment of cancer |
| 08/19/2004 | WO2004055201A3 Cholesterol 24-hydroxylase (cyp46) as therapeutic target for the treatment of alzheimer's disease |
| 08/19/2004 | WO2004053474A3 Gas detector for indicating failure of equipment or for monitoring ambient air |
| 08/19/2004 | WO2004052920A9 Conversion of apoptotic proteins |
| 08/19/2004 | WO2004050903A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c) |
| 08/19/2004 | WO2004050702A3 Novel ifngamma-like polypeptides |
| 08/19/2004 | WO2004048536A3 Rhebs as modifiers of the rb pathway and methods of use |
| 08/19/2004 | WO2004048414A3 Holo-transcobalamins binding partners and their use in cobalamin assay |
| 08/19/2004 | WO2004046725A3 Substrates with biological membrane arrays and methods for their fabrication |
| 08/19/2004 | WO2004044569A3 Mems membrane based sensor |
| 08/19/2004 | WO2004042353A3 Identifying therapeutic compounds based on their physical-chemical properties |
| 08/19/2004 | WO2004040307A3 Device and method for analyzing the structure of complex glycostructures and for detecting same |
| 08/19/2004 | WO2004038767A3 Doped nanoscale wires and method of manufacture |
| 08/19/2004 | WO2004037371A8 Assay for determining the activity of fatty acid amide hydrolase |
| 08/19/2004 | WO2004036188A3 Processes for identifying quadruplex-targeted antiviral molecules |
| 08/19/2004 | WO2004035812A3 Asparaginyl hydroxylases and modulators thereof |
| 08/19/2004 | WO2004035808A9 Method for detecting viral inactivating agents |
| 08/19/2004 | WO2004032716A9 Compounds for modulation of cholesterol transport |
| 08/19/2004 | WO2004031809A3 Optical tomography of small moving objects using time delay and integration imaging |
| 08/19/2004 | WO2004029583A3 Methods of secretory vimentin detection and modulation |
| 08/19/2004 | WO2004029285A3 Methods for detecting endocrine cancer |
| 08/19/2004 | WO2004027428A8 Method for detecting and isolating t lymphocytes that recognize a defined antigen |
| 08/19/2004 | WO2004026120A3 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 08/19/2004 | WO2004026114A3 Quantification of carnitine levels in dialysis patients |
| 08/19/2004 | WO2004024076A9 Novel compositions and methods for the treatment of immune related diseases |
| 08/19/2004 | WO2004017909A3 Methods of reducing ischemic injury |
| 08/19/2004 | WO2004003509A3 A method to identify specific interaction between ligand and receptor |
| 08/19/2004 | WO2004001371A3 Receptor capture assay |
| 08/19/2004 | WO2003104765A3 Total organic carbon (toc) analyzer |
| 08/19/2004 | WO2003101388A3 Human solute carrier family 7 member 11 (hslc7a11) |
| 08/19/2004 | WO2003095663A3 Modified t lymphocytes and uses therefor |
| 08/19/2004 | WO2003089937A3 Quantitation of biological molecules |